Unknown PHASE2 INTERVENTIONAL 2-arm NCT01301248

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Phase II Safety and Toxicity Study of Cisplatin With or Without Cetuximab and Concomitant Radiotherapy for Locoregionally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Sponsor: Theagenio Cancer Hospital

Conditions AJCC Stage III/IV Head and Neck Neoplasms

Interventions Chemoradiation Chemoradiation plus Cetuximab

Updated 6 times since 2017 Last updated: May 16, 2011 Started: Mar 31, 2008 Primary completion: Apr 30, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on AJCC Stage III/IV and Head and Neck Neoplasms, this trial is ongoing. The trial is conducted by Theagenio Cancer Hospital and has accumulated 6 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Theagenio Cancer Hospital

Data source: Theagenio Cancer Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Thessaloniki, Greece